Cadre (NYSE:CDRE) Stock Rating Lowered by Wall Street Zen

Cadre (NYSE:CDRE) was downgraded by analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a note issued to investors on Saturday.

Separately, Bank of America downgraded Cadre from a “buy” rating to a “neutral” rating and dropped their price target for the stock from $45.00 to $38.00 in a research report on Friday, June 13th.

Cadre Stock Performance

Shares of Cadre stock opened at $30.52 on Friday. The stock’s fifty day moving average is $33.03 and its two-hundred day moving average is $33.09. The company has a market capitalization of $1.24 billion, a PE ratio of 32.47, a price-to-earnings-growth ratio of 1.14 and a beta of 1.31. The company has a quick ratio of 2.57, a current ratio of 3.59 and a debt-to-equity ratio of 0.90. Cadre has a 52 week low of $27.07 and a 52 week high of $40.28.

Cadre (NYSE:CDRE) last announced its quarterly earnings data on Tuesday, August 5th. The company reported $0.30 EPS for the quarter, beating the consensus estimate of $0.25 by $0.05. Cadre had a return on equity of 12.08% and a net margin of 6.65%. The company had revenue of $157.11 million for the quarter, compared to the consensus estimate of $153.23 million. During the same quarter in the prior year, the company posted $0.31 EPS. Cadre’s quarterly revenue was up 8.9% on a year-over-year basis. As a group, analysts expect that Cadre will post 1.05 earnings per share for the current year.

Insiders Place Their Bets

In related news, CEO Warren B. Kanders sold 25,000 shares of the firm’s stock in a transaction dated Monday, June 23rd. The stock was sold at an average price of $32.78, for a total transaction of $819,500.00. Following the sale, the chief executive officer owned 10,216,192 shares of the company’s stock, valued at $334,886,773.76. This trade represents a 0.24% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders sold a total of 275,000 shares of company stock worth $9,309,000 over the last 90 days. 37.00% of the stock is owned by company insiders.

Institutional Investors Weigh In On Cadre

Institutional investors have recently added to or reduced their stakes in the stock. Huntington National Bank boosted its position in Cadre by 48.4% during the second quarter. Huntington National Bank now owns 960 shares of the company’s stock valued at $31,000 after purchasing an additional 313 shares in the last quarter. Assetmark Inc. raised its stake in Cadre by 43.1% in the second quarter. Assetmark Inc. now owns 1,395 shares of the company’s stock valued at $44,000 after buying an additional 420 shares during the last quarter. Militia Capital Partners LP purchased a new stake in Cadre in the first quarter valued at about $49,000. State of Wyoming purchased a new stake in Cadre in the first quarter valued at about $69,000. Finally, Harel Insurance Investments & Financial Services Ltd. raised its stake in Cadre by 37.7% in the first quarter. Harel Insurance Investments & Financial Services Ltd. now owns 4,221 shares of the company’s stock valued at $125,000 after buying an additional 1,155 shares during the last quarter. Institutional investors own 43.95% of the company’s stock.

About Cadre

Cadre Holdings, Inc manufactures and distributes safety that provides protection to users in hazardous or life-threatening situations in the United States and internationally. The company operates in two segments, Products and Distribution. It offers body armor product, such as concealable, corrections, and tactical armor under the Safariland and Protech Tactical brand names; survival suits, remotely operated vehicles, specialty tools, blast sensors, accessories, and vehicle blast attenuation seats for bomb safety technicians; bomb suits; duty gear, including belts and accessories; and other protective equipment comprising communications gear, forensic and investigation products, firearms cleaning solutions, and crowd control products.